ELIL
Get informed when a big investor buys or sells
+ Follow| Market cap | $19.45 Million |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $3.17 (10.99%) |
| Earnings per Share | $- |
| Beta | 0.42 |
| Outstanding Shares | - |
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 26.93%▲ 26.93% |
|---|---|
| Total Invested | $3.51M |
| Investors Holding | 6▲ 6.00% |
No data
The Direxion Daily LLY Bull 2X ETF is engineered to deliver daily investment results that are twice (200%) the performance of Eli Lilly and Company's (LLY) common shares. Conversely, the Direxion Daily LLY Bear 1X ETF endeavors to provid...